Table 5.
Cost model
| Coef | p value | |
|---|---|---|
| Health state (ref. A&S) | ||
| HF | 1922.7 | 0.095 |
| MACE | 92.6 | 0.884 |
| RF | 395.6 | 0.723 |
| Control variables | ||
| Age (ref. < 50) | ||
| 50–75 | 254.8 | 0.800 |
| > 75 | 224.4 | 0.843 |
| Male | 509.0 | 0.425 |
| Diabetes | 6.2 | 0.992 |
| BMI (ref. normal or underweight) | ||
| Overweight | 27.0 | 0.962 |
| Obese | − 447.3 | 0.531 |
| CVD history | 425.9 | 0.430 |
| Risk factor | 260.6 | 0.718 |
| Cons | − 19.1 | 0.988 |
| N—number of patients | 322 | |
| N—number of patient-follow-ups | 634 | |
The constant of the model represents a female patient, in the A&S state, younger than 50, with no diabetes, normal or underweight, no CVD history and no risk factors. MACE included patients with urgent revascularization, MI or stroke